Immune‐Driven Expression in Inclusion Body Myositis With T‐Cell Large Granular Lymphocytic Leukemia
IBM is the most common myopathy in T-LGLL patients. While clinico-sero-pathological features were largely similar, transcriptomic differences suggest IBM with T-LGLL may represent a distinct, more immune-driven subtype.
Authors
- Iago Pinal‐Fernandez (ORCID: https://orcid.org/0000-0001-6338-9218)
- Pritikanta Paul (ORCID: https://orcid.org/0000-0001-9842-8803)
- Maleeha Shah
- Michael Skolka (ORCID: https://orcid.org/0009-0006-5155-4371)
- Andrew L. Mammen
- Pannathat Soontrapa
- Maria Casal‐Dominguez
- Katherine Pak
- Min Shi
Institutions
- Mayo Clinic (US)
- Siriraj Hospital (TH)
- Johns Hopkins University (US)
- University of California, San Francisco (US)
- Johns Hopkins Medicine (US)
- Jacksonville College (US)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1002/acn3.70301
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases